VivoSeq
Other

Plantar Fasciopathy

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Plantar Fasciopathy is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Completed3 · 60%
Not yet recruiting2 · 40%

Clinical Trials

Trial Activity

Effectiveness of Infiltrations in the Treatment of Plantar Fasciopathy
Not yet recruiting·UUniversity of Seville·N/A·NCT06671223·200 enrolled
Advice vs Advice + Exercise vs Advice + Exercise + Injection for Individuals With Plantar Fasciopathy
Completed·—·N/A·NCT03804008·180 enrolled
Early Intervention With Therapeutic Exercise in Plantar Fasciopathy
Not yet recruiting·UUniversidad Miguel Hernandez de Elche·N/A·NCT06394336·60 enrolled
Heavy-slow Resistance Training and Ultrasound-guided Corticosteroid Injection in Plantar Fasciopathy
Completed·—·N/A·NCT03535896·20 enrolled
QUANTIFY: Quantitative Understanding of Advanced Novel Techniques for Imaging Fasciitis and Yielding Biomarkers
Completed·—·Preclinical·NCT06803056·106 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)